Quick Answer
AXIM BIOTECHNOLOGIES, INC. reported Total Assets of $4.12 million for the year ending 2023.
- AXIM BIOTECHNOLOGIES, INC. showed a decrease of -2.1% in Total Assets from 2022 to 2023.
- This data is from AXIM BIOTECHNOLOGIES, INC.'s annual report (Form 10-K), filed with the SEC on April 16, 2024.
- XBRL data for this metric is available from 2010 to 2023 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $87.1 thousand | Q2 2012: $58.3 thousand | Q3 2012: $67.9 thousand | Q1 2013: $125.6 thousand | Q2 2013: $96.3 thousand | Q3 2013: $90.9 thousand | Q3 2014: $1.06 million | Q4 2014: $738.5 thousand | Q1 2015: $235.6 thousand | Q3 2015: $1.82 million | Q1 2017: $824.8 thousand | Q2 2017: $4.41 million | Q3 2017: $3.32 million | Q3 2018: $791.7 thousand | Q4 2018: $2.09 million | Q1 2019: $3.02 million | Q2 2019: $2.88 million | Q3 2019: $2.38 million | Q4 2020: $11.31 million | Q2 2021: $10.35 million | Q3 2021: $14.25 million | Q1 2022: $5.06 million | Q2 2022: $4.52 million | Q1 2023: $4.04 million | Q2 2023: $4.25 million | Q3 2023: $4.04 million | Q4 2023: $4.12 million | Q1 2024: $3.93 million | Q2 2024: $3.73 million.
- Historical annual values: Fiscal year 2023: $4.12 million | Fiscal year 2022: $4.21 million | Fiscal year 2021: $5.32 million | Fiscal year 2018: $2.09 million | Fiscal year 2017: $2.19 million | Fiscal year 2016: $1.45 million | Fiscal year 2014: $738.5 thousand | Fiscal year 2013: $56.8 thousand | Fiscal year 2012: $132.8 thousand | Fiscal year 2011: $137.3 thousand | Fiscal year 2010: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: